Prognostic value of capillary refill time in adult patients: a systematic review with meta-analysis

Table 2 Primary and secondary analyses

	Number of studies	Number of patient	AUC ROC	95%CI	OR	95%CI	Tau²	I²	P value
Primary analysis (Mortality in ACF patients)	13	1038	0.66	[0.59; 0.76]	3.4	[1.4; 8.3]	1.4	79%	0.013
Secondary analysis (Mortality or adverse event in patients at risk or confirmed ACF)	23	59,522	0.69	[0.65; 0.74]	4.3	[2.6; 7.3]	0.9	96%	< 0.001
Secondary analysis (Comparison of CRT and Lactate)
CRT	9	7023	0.68	[0.60; 0.79]	3.2	[1.1; 9.1]	0.7	77%	0.687
Lactate	9	7023	0.54	[0.53; 0.55]	2.6	[1.3; 5.2]	0.8	81%

ACF Acute circulatory failure, AUC ROC Area under the curve of the receiver operating characteristic CI Confidence interval, OR Odds ratio. P value stands for the P value the effect size with the random effect model for the two first analysis and the comparison of the effect size between lactate and CRT in the last analysis

ISSN: 1364-8535